PRS50 - Cost-Effectiveness Of A 13-Valent Conjugate Pneumococcal Vaccination Program In Copd Patients Aged 50+ Years In Spain

Autor: Rodríguez-GonzálezMoro, JM, Menendez, R, Campins, M, Lwoff, N, Oyagüez, I, Echave, M, Rejas, J, Antoñanzas, F
Zdroj: In Value in Health November 2015 18(7):A502-A502
Databáze: ScienceDirect